PSI works to shape the industry by promoting good practice for pharmaceutical statisticians in the scientific literature [1, 2], by promoting the value of
statistical insight in the development of medicines with our directory of consultants and by lobbying to increase statistical
input in regulatory decisions .
Our regulatory committee reviews and comments on regulatory guidelines on behalf of industry statisticians. Our special interest groups and working parties are forums for statisticians to share experiences and form guidelines for good practice in their
specific areas of expertise.
PSI is a member of EFSPI, the European federation of national pharmaceutical statistics bodies and participates through EFSPI in Europe-wide industry discussions.
If you wish to contribute to any of these activities, contact email@example.com.